Zhang et al. reported that Rg3 effectively mitigated glucocorticoid-induced osteoporosis through modulation of the bone morphogenic protein-2 (BMP-2)/BMP receptor 1A (BMPR1A)/Runx2 signaling pathway [91]. The gene discussed is RUNX2; the disease is osteoporosis.